Cargando…
Targeting cancer testis antigens in synovial sarcoma
Synovial sarcoma (SS) is a rare cancer that disproportionately affects children and young adults. Cancer testis antigens (CTAs) are proteins that are expressed early in embryonic development, but generally not expressed in normal tissue. They are aberrantly expressed in many different cancer types a...
Autores principales: | Mitchell, Geoffrey, Pollack, Seth M, Wagner, Michael J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183285/ https://www.ncbi.nlm.nih.gov/pubmed/34083416 http://dx.doi.org/10.1136/jitc-2020-002072 |
Ejemplares similares
-
Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review
por: Riedel, Richard F., et al.
Publicado: (2018) -
The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients
por: Pollack, Seth M.
Publicado: (2017) -
Propranolol for the treatment of vascular sarcomas
por: Wagner, Michael J, et al.
Publicado: (2018) -
Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013) -
Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
por: Shim, Kyeonghee, et al.
Publicado: (2023)